Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 0.75 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.

Expert Illustrations and Commentaries: Finding the Best Path Forward in PAH Management - A Focus on Prostacyclin Therapy

Release Date: November 30, 2021
Expiration Date: November 30, 2022

Activity Overview

This Expert Illustrations and CommentariesTM is a video-based program in which 2 experts discuss the role of prostacyclin therapy in the management of pulmonary arterial hypertension (PAH). In this activity, the faculty focus on methods to facilitate an accurate and early diagnosis of PAH, as well as best practices in individualizing PAH treatment. Their discussion is enriched with the use of a video animation to illustrate the mechanism of action of prostacyclin therapy in PAH. The use of this animated segment helps make somewhat complicated subject matter more easily understood. This unique format is designed to help clinicians identify best practices in the diagnosis and management of PAH and to improve outcomes for their patients with this disease.
 

Acknowledgement of Commercial Support

This activity is supported by educational grants from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.
 

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational activity is directed toward pulmonologists, cardiologists, rheumatologists, primary care physicians, nurse practitioners, physician assistants, and additional health care professionals involved in the care of patients with PAH.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Determine best practices for identifying patients at risk of PAH
  • Review available assessment tools for prompt diagnosis and classification of PAH  
  • Assess the safety and efficacy of new and emerging therapies for the management of patients with PAH
  • Develop individualized treatment plans based on current practice guidelines for optimal management of patients with PAH
     

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies. 
 

Faculty

Vivian Laquer, MD, FAAD
Kristin Highland, MD, MSCR
Director, Rheumatic Lung Disease Program
Pulmonary Department
Cleveland Clinic
Cleveland, OH
 

Disclosures: Grant/Research Support: Actelion Pharmaceuticals US, Inc.; Acceleron Pharma; Boehringer Ingelheim; Gossamer Bio; Reata Pharmaceuticals; United Therapeutics; Viela Bio, Inc.; Consultant: Actelion Pharmaceuticals US, Inc.; Acceleron Pharma; Boehringer Ingelheim; United Therapeutics; Speakers’ Bureau: Actelion Pharmaceuticals US, Inc.; Bayer; United Therapeutics; Boehringer Ingelheim.
 

 
Vivian Laquer, MD, FAAD
Deborah Jo Levine MD FCCP
Professor of Medicine
Pulmonary and Critical Care Medicine
Director of Pulmonary Hypertension
University of Texas San Antonio
San Antonio, Texas

Disclosures: Dr. Deborah Jo Levine MD FCCP has no relevant financial relationships with ineligible companies.


PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
 

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
31
Filter By